Stryker (SYK) Free Cash Flow (QoQ) (2009 - 2026)
Stryker (SYK) Free Cash Flow (QoQ) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.32 Bn | 177.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.89 Bn | 126.01 Bn | 3.81 Bn |
| 3 | Medtronic | 108.88 Bn | 99.66 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.65 Bn | 67.20 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.43 Bn | 43.76 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.48 Bn | 26.19 Bn | 1.98 Bn |
| 7 | Dexcom | 28.45 Bn | 27.33 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.98 Bn | 26.40 Bn | - |
| 9 | Koninklijke Philips | 25.54 Bn | 22.42 Bn | 2.07 Bn |
| 10 | Steris | 21.57 Bn | 21.13 Bn | 697.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -77.87% |
| Dec 31, 2025 | 38.58% |
| Sep 30, 2025 | 45.80% |
| Jun 30, 2025 | 630.71% |
| Mar 31, 2025 | -92.37% |
| Dec 31, 2024 | 27.68% |
| Sep 30, 2024 | 171.10% |
| Jun 30, 2024 | 1,200.00% |
| Mar 31, 2024 | -97.32% |
| Dec 31, 2023 | 53.33% |
| Sep 30, 2023 | 68.28% |
| Jun 30, 2023 | 70.16% |
| Mar 31, 2023 | -61.35% |
| Dec 31, 2022 | 8.52% |
| Sep 30, 2022 | 94.56% |
| Jun 30, 2022 | 359.52% |
| Mar 31, 2022 | -89.42% |
| Dec 31, 2021 | -1.12% |
| Sep 30, 2021 | 4.02% |
| Jun 30, 2021 | 109.21% |